Human breast cancer cell line xenografts as models of breast cancer - The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines

被引:101
作者
Clarke, R [1 ]
机构
[1] GEORGETOWN UNIV,SCH MED,DEPT PHYSIOL & BIOPHYS,WASHINGTON,DC 20007
关键词
xenografts; breast cancer; cell lines; resistance;
D O I
10.1007/BF01806079
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The ability to maintain and study human tissues in an in vivo environment has proved to be a valuable tool in breast cancer research for several decades. The most widely studied tissues have been xenografts of established human breast cancer cell lines into athymic nude mice. Human breast tumor xenografts provide the opportunity to study various important interactions between the tumor and host tissues, including endocrinologic, immunologic, and tumor-stroma interactions. The nude mouse is not the only immune-deficient recipient system in which to study xenografts. Additional single and combined mutant strains have been used successfully, including mice homozygous for the severe combined immune deficiency mutation (scid), both the beige (bg) and nude (nu) mutations in combination (bg/nu), and mice bearing the combined bg/nu/xid mutations. The differing immunobiologies are discussed, with particular reference to the immunobiology of breast cancer, as are the characteristics of several of the more frequently utilized breast cancer xenografts and cell lines. The ability of several endocrine treatments to modulate effecters of cell mediated immunity, e.g., estrogens and antiestrogens, and the effect of site of inoculation on tumor take and metastasis, also are described.
引用
收藏
页码:69 / 86
页数:18
相关论文
共 149 条
[1]   EFFECT OF HYDROCORTISONE ON THE MACROPHAGE CONTENT, GROWTH AND METASTASIS OF TRANSPLANTED MURINE TUMORS [J].
ACERO, R ;
POLENTARUTTI, N ;
BOTTAZZI, B ;
ALBERTI, S ;
RICCI, MR ;
BIZZI, A ;
MANTOVANI, A .
INTERNATIONAL JOURNAL OF CANCER, 1984, 33 (01) :95-105
[2]   B-LYMPHOCYTE HETEROGENEITY - DEVELOPMENT AND CHARACTERIZATION OF AN ALLOANTISERUM WHICH DISTINGUISHES B-LYMPHOCYTE DIFFERENTIATION ALLOANTIGENS [J].
AHMED, A ;
SCHER, I ;
SHARROW, SO ;
SMITH, AH ;
PAUL, WE ;
SACHS, DH ;
SELL, KW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 145 (01) :101-110
[3]  
AKIMOTO M, 1986, CANCER DETECT PREV, V9, P311
[4]  
AN T, 1987, AM J PATHOL, V128, P52
[5]  
ANDRIOLE GL, 1985, J IMMUNOL, V135, P2911
[6]  
AZAR HA, 1980, J NATL CANCER I, V65, P421
[7]   MACROPHAGE ACTIVATION AND INNATE RESISTANCE TO INFECTION IN SCID MICE [J].
BANCROFT, GJ ;
KELLY, JP .
IMMUNOBIOLOGY, 1994, 191 (4-5) :424-431
[8]  
BATIST G, 1986, J BIOL CHEM, V261, P5544
[9]  
BEAMER WG, 1993, CANCER RES, V53, P3741
[10]   TAMOXIFEN WITHDRAWAL RESPONSE - REPORT OF A CASE [J].
BELANI, CP ;
PEARL, P ;
WHITLEY, NO ;
AISNER, J .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (02) :449-450